               SEQUENCE LISTING

<110> NeuBase Therapeutics, Inc.

<120> PYRMIDINE-COMPLIANT PEPTIDE NUCLEIC ACID COMPOSITIONS AND METHODS OF USE THEREOF

<130> 54344-727.601

<140> PCT/US22/35328
<141> 2022-06-28

<150> 63/215,698
<151> 2022-06-28

<160> 13

<170> BiSSAP 1.3.6

<210> 1
<211> 22
<212> DNA
<213> Artificial Sequence


<220> 
<223> Description of Artificial Sequence: Synthetic oligonucleotide

<400> 1
cacctgactc ctgtggagaa gt                                             22


<210> 2
<211> 14
<212> DNA
<213> Artificial Sequence


<220> 
<223> Description of Artificial Sequence: Synthetic oligonucleotide

<400> 2
aggagcaggg aggg                                                      14


<210> 3
<211> 15
<212> DNA
<213> Artificial Sequence


<220> 
<223> Description of Artificial Sequence: Synthetic oligonucleotide

<400> 3
ggggcaaggt gaacg                                                     15


<210> 4
<400> 4
000

<210> 5
<400> 5
000

<210> 6
<400> 6
000

<210> 7
<211> 14
<212> DNA
<213> Artificial Sequence


<220> 
<223> Description of Artificial Sequence: Synthetic oligonucleotide

<400> 7
ggagacagag aaga                                                      14


<210> 8
<211> 14
<212> DNA
<213> Artificial Sequence


<220> 
<223> Description of Artificial Sequence: Synthetic oligonucleotide

<400> 8
ggagatagag aaga                                                      14


<210> 9
<211> 9
<212> DNA
<213> Artificial Sequence


<220> 
<223> Description of Artificial Sequence: Synthetic oligonucleotide

<400> 9
agggagagg                                                            9


<210> 10
<211> 9
<212> DNA
<213> Artificial Sequence


<220> 
<223> Description of Artificial Sequence: Synthetic oligonucleotide

<400> 10
agggcgagg                                                            9


<210> 11
<211> 9
<212> DNA
<213> Artificial Sequence


<220> 
<223> Description of Artificial Sequence: Synthetic oligonucleotide

<400> 11
agggggagg                                                            9


<210> 12
<211> 9
<212> DNA
<213> Artificial Sequence


<220> 
<223> Description of Artificial Sequence: Synthetic oligonucleotide

<400> 12
agggtgagg                                                            9


<210> 13
<211> 516
<212> DNA
<213> Artificial Sequence


<220> 
<223> Description of Artificial Sequence: Synthetic oligonucleotide

<400> 13
acggctgtca tcacttagac ctcaccctgt ggagccacac cctagggttg gccaatctac      60

tcccaggagc agggagggca ggagccaggg ctgggcataa aagtcagggc agagccatct     120

attgcttaca tttgcttctg acacaactgt gttcactagc aacctcaaac agacaccatg     180

gtgcacctga ctcctgtgga gaagtctgcc gttactgccc tgtggggcaa ggtgaacgtg     240

gatgaagttg gtggtgaggc cctgggcagg ttggtatcaa ggttacaaga caggtttaag     300

gagaccaata gaaactgggc atgtggagac agagaagact cttgggtttc tgataggcac     360

tgactctctc tgcctattgg tctattttcc cacccttagg ctgctggtgg tctacccttg     420

gacccagagg ttctttgagt cctttgggga tctgtccact cctgatgctg ttatgggcaa     480

ccctaaggtg aaggctcatg gcaagaaagt gctcgg                               516


